Replies to post #229413 on Biotech Values

[randychub]

Just the pandemic

[Bickema]

RVNC I would say...

1. Toxins are a luxury item (cosmetic)
2. FDA approval could be delayed
3. Company has several long term clinical trials that may be delayed by patient compliance especially the aesthetic trials
4. Large cash burn

[Bickema]

RVNC / EOLS - it is troubling seeing EOLS up 9% today and RNVC down 6%. In fact RVNC is one of the few red bios that I am following.

Perhaps a leak of Mylan's decision?